Relative Value Partners’s Pfizer PFE Stock Holding History

Relative Value Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$435K	Sell	13,175 -481	-4%	-$15.3K	0.05%	82
2014 Q4	$404K	Hold	13,656	–	–	0.05%	87
2014 Q3	$383K	Buy	13,656 +264	+2%	+$7.41K	0.05%	74
2014 Q2	$377K	Buy	13,392 +264	+2%	+$7.53K	0.05%	66
2014 Q1	$400K	Buy	13,128 +1,581	+14%	+$47.1K	0.05%	67
2013 Q4	$336K	Hold	11,547	–	–	0.05%	71
2013 Q3	$315K	Hold	11,547	–	–	0.05%	64
2013 Q2	$307K	Buy	+11,547	New	+$319K	0.05%	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Relative Value Partners's PFE Position: Q1 2015 in Review

Relative Value Partners reduced its Pfizer (PFE) stake by 3.5% in Q1 2015, selling an estimated $15.3K and leaving 13,175 shares worth $435K. The position accounts for 0.05% of the portfolio, ranked #82.

Relative Value Partners first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. 1,874 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Relative Value Partners held 13,175 shares of Pfizer worth $435K as of Q1 2015.
Relative Value Partners sold 481 Pfizer shares in Q1 2015, an estimated $15.3K.
Pfizer made up 0.05% of Relative Value Partners's portfolio in Q1 2015, its #82 holding.
Relative Value Partners first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
1,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Relative Value Partners's 13F filing for Q1 2015, filed 14 May 2015.